Adreview Injection
Product Images NDC 17156-235

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Adreview (NDC 17156-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medi-physics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Adreview 01)

Chemical structure diagram of Iobenguane I-123, the active ingredient in AdreView injection 2 mCi/mL by Medi-Physics Inc. The image shows a labeled molecular structure representing the compound used for intravenous administration.*

FDA Label Image

Figure 2a (Adreview 02)

Chemical structure image shows a grayscale, somewhat blurry molecular or radiographic pattern, likely related to the active ingredient Iobenguane I-123 used in AdreView injection.*

FDA Label Image

Figure 2b (Adreview 03)

FDA Label Image

Figure 3 (Adreview 04)

An annotated medical imaging scan showing labeled anatomical areas including the mediastinum and heart. The image highlights these regions with lines and boxes for reference, likely related to the use of AdreView (Iobenguane I-123) injection in diagnostic imaging.*

FDA Label Image

Figure 4 (Adreview 05)

A two-panel nuclear medicine image showing Iobenguane I-123 uptake in the chest area, demonstrating heart-to-mediastinum (H/M) ratios of 2.21 and 2.03, respectively. These scintigraphic images illustrate radiotracer distribution relevant to AdreView (Iobenguane I-123) diagnostic injection.*

FDA Label Image

Chemical Structure (Adreview 06)

Chemical structure of Iobenguane I-123 as shown in the image, including its sulfate salt form. The diagram depicts the arrangement of atoms in the molecule with iodine-123 labeled on the benzene ring.*

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for AdreView injection containing Iobenguane I-123 with a strength of 2 mCi/mL (74 MBq/mL) provided as a 5 mL solution. The label notes it is a sterile, pyrogen-free radiodiagnostic agent for intravenous use only, with specific calibration details. Manufactured by Medi-Physics Inc., the label includes regulatory and safety information including a radioactive material caution symbol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.